BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1375043)

  • 1. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
    Tombolini V; Capua A; Pompili E
    Acta Oncol; 1992; 31(1):64-5. PubMed ID: 1375043
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of chemotherapy in the management of early stage Hodgkin's disease.
    Rosenberg SA
    Hematol Oncol; 1984; 2(1):61-3. PubMed ID: 6203821
    [No Abstract]   [Full Text] [Related]  

  • 3. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H
    Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 7. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Busia A; Laffranchi A; Viviani S; Bonfante V; Villani F
    Anticancer Res; 2010 Oct; 30(10):4381-7. PubMed ID: 21036768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

  • 10. Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
    Bonadonna G; Santoro A; Viviani S; Lombardi C; Ragni G
    Arch Toxicol Suppl; 1984; 7():140-5. PubMed ID: 6083763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of childhood Hodgkin's disease without radiotherapy.
    van den Berg H; Zsiros J; Behrendt H
    Ann Oncol; 1997; 8 Suppl 1():15-7. PubMed ID: 9187423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 13. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    Delwail V; Jais JP; Colonna P; Andrieu JM
    Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
    Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
    Veronesi G; Spaggiari L; Solli PG; Leo F; Villa G; Pastorino U
    Ann Oncol; 2002 Dec; 13(12):1945-7. PubMed ID: 12453864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
    Glick JH; Young ML; Harrington D; Schilsky RL; Beck T; Neiman R; Fisher RI; Peterson BA; Oken MM
    J Clin Oncol; 1998 Jan; 16(1):19-26. PubMed ID: 9440718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
    Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.